Design of novel urogenital pharmabiotic formulations containing lactobacilli, salivaricin CRL 1328 and non-microbial compounds with different functionalities

References

• Kumar N, Behera B, Sagiri SS, et al. Bacterial vaginosis: etiology and modalities of treatment – A brief note. J Pharm Bioallied Sci 2011;3:496–503
   PubMedGoogle Scholar
• Reid G. Probiotic and prebiotic applications for vaginal health. J AOAC Int 2012;95:31–4
   PubMed Web of Science ®Google Scholar
• Reid G, Younes JA, Van der Mei HC, et al. Microbiota restoration: natural and supplemented recovery of human microbial communities. Nat Rev Microbiol 2011;9:27–38
   PubMed Web of Science ®Google Scholar
• Food and Agriculture Organization of the United Nations and World Health Organization. Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Córdoba; 2001
   Google Scholar
• Shanahan F, Stanton C, Ross P, Hill C. Pharmabiotics: Bioactives from mining host-microbe-dietary interactions. Funct Food Rev 2009;1:20–5
   Google Scholar
• Ocaña VS, Bru E, Pesce de Ruiz Holgado A, Nader-Macías ME. Surface characteristics of lactobacilli isolated from human vagina. J Gen Appl Microbiol 1999;45:203–12
   PubMed Web of Science ®Google Scholar
• Juárez Tomás MS, Ocaña VS, Wiese B, Nader-Macías ME. Growth and lactic acid production by vaginal Lactobacillus acidophilus CRL 1259, and inhibition of uropathogenic Escherichia coli. J Med Microbiol 2003;52:1117–24
   PubMed Web of Science ®Google Scholar
• Ocaña VS, Pesce de Ruiz Holgado A, Nader-Macías ME. Characterization of a bacteriocin-like substance produced by a vaginal Lactobacillus salivarius strain. Appl Environ Microbiol 1999;65:5631–5
   PubMed Web of Science ®Google Scholar
• Juárez Tomás MS, Bru E, Wiese B, et al. Influence of pH, temperature and culture media on the growth and bacteriocin production by vaginal Lactobacillus salivarius CRL 1328. J Appl Microbiol 2002;93:714–24
   PubMed Web of Science ®Google Scholar
• Vera Pingitore E, Hébert EM, Nader-Macías ME, Sesma F. Characterization of salivaricin CRL 1328, a two-peptide bacteriocin produced by Lactobacillus salivarius CRL 1328 isolated from the human vagina. Res Microbiol 2009;160:401–8
   PubMed Web of Science ®Google Scholar
• Juárez Tomás MS, Saralegui Duhart CI, De Gregorio PR, et al. Urogenital pathogen inhibition and compatibility between vaginal Lactobacillus strains to be considered as probiotic candidates. Eur J Obstet Gynecol Reprod Biol 2011;159:399–406
   PubMed Web of Science ®Google Scholar
• Choudhury A, Das S, Kar M. A review on novelty and potentiality of vaginal drug delivery. Int J PharmTech Res 2011;3:1033–44
   Google Scholar
• Marrazzo JM, Cook RL, Wiesenfeld HC, et al. Women’s satisfaction with an intravaginal Lactobacillus capsule for the treatment of bacterial vaginosis. J Womens Health 2006;15:1053–60
   PubMed Web of Science ®Google Scholar
• Zárate G, Juárez Tomás MS, Nader-Macías ME. Effect of some pharmaceutical excipients on the survival of probiotic vaginal lactobacilli. Can J Microbiol 2005;51:483–9
   PubMed Web of Science ®Google Scholar
• Juárez Tomás MS, Bru E, Martos G, Nader-Macias ME. Stability of freeze-dried vaginal Lactobacillus strains in the presence of different lyoprotectors. Can J Microbiol 2009;55:544–52
   PubMed Web of Science ®Google Scholar
• Lee KH, Salminen S. Part II: prebiotics. In: Lee KH, Salminen S, eds. Handbook of probiotics and prebiotics. 2nd ed. New Jersey: John Wiley & Sons; 2009:533–82
   Google Scholar
• de Vrese M. Health benefits of probiotics and prebiotics in women. Menopause Int 2009;15:35–40
   PubMedGoogle Scholar
• Vera Pingitore E, Bru E, Nader-Macías ME. Effect of lyophilization and storage temperature on the activity of salivaricin CRL 1328, a potential bioactive ingredient of a urogenital probiotic product. J Gen Appl Microbiol 2012;58:71–81
   PubMed Web of Science ®Google Scholar
• Ocaña V, Silva C, Nader-Macías ME. Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. Infect Dis Obstet Gynecol 2006;2006:(Article ID18182) 1–6
   Google Scholar
• Jack RW, Tagg JR, Ray B. Bacteriocins of gram-positive bacteria. Microbiol Rev 1995;59:171–200
   PubMedGoogle Scholar
• Huet S, Bouvier A, Gruet MA, Jolivet E. Accuracy of estimators, confidence intervals and tests. In: Huet S, Bouvier A, Gruet MA, Jolivet E, eds. Statistical tools for nonlinear regression. New York: Springer-Verlag; 1996:29–59
   Google Scholar
• MacPhee RA, Hummelen R, Bisanz JE, et al. Probiotic strategies for the treatment and prevention of bacterial vaginosis. Expert Opin Pharmacother 2010;11:2985–95
   PubMed Web of Science ®Google Scholar
• Reid G, Soboh F, Bruce AW, Mittelman M. Effect of nutrient composition on the in vitro growth of urogenital lactobacilli and uropathogens. Can J Microbiol 1998;44:866–71
   PubMed Web of Science ®Google Scholar
• Drago L, Rodighiero V, Celeste T, et al. Microbiological evaluation of commercial probiotic products available in the USA in 2009. J Chemother 2010;22:373–7
   PubMed Web of Science ®Google Scholar
• Jalali M, Abedi D, Varshosaz J, et al. Stability evaluation of freeze-dried Lactobacillus paracasei subsp. tolerance and Lactobacillus delbrueckii subsp. bulgaricus in oral capsules. Res Pharm Sci 2012;7:31–6
   PubMedGoogle Scholar
• Ying DY, Phoon MC, Sanguansri L, et al. Microencapsulated Lactobacillus rhamnosus GG powders: relationship of powder physical properties to probiotic survival during storage. J Food Sci 2010;75:588–95
   PubMed Web of Science ®Google Scholar
• Carvalho AS, Silva J, Ho P, et al. Relevant factors for the preparation of freeze-dried lactic acid bacteria. Int Dairy J 2004;14:835–47
   Web of Science ®Google Scholar
• Portner DC, Leuschner RG, Murray BS. Optimising the viability during storage of freeze-dried cell preparations of Campylobacter jejuni. Cryobiology 2007;54:265–70
   PubMed Web of Science ®Google Scholar
• Carvalho AS, Silva J, Ho P, et al. Effect of various growth media upon survival during storage of freeze-dried Enterococcus faecalis and Enterococcus durans. J Appl Microbiol 2003;94:947–52
   PubMed Web of Science ®Google Scholar
• Otero MC, Espeche MC, Nader-Macías ME. Optimization of the freeze-drying media and survival throughout storage of freeze-dried Lactobacillus gasseri and Lactobacillus delbrueckii subsp. delbrueckii for veterinarian probiotic applications. Process Biochem 2007;42:1406–11
   Web of Science ®Google Scholar
• Diep DB, Skaugen M, Salehian Z, et al. Common mechanisms of target cell recognition and immunity for class II bacteriocins. Proc Natl Acad Sci USA 2007;13:2384–9
   Web of Science ®Google Scholar
• Drider D, Fimland G, Hechard Y, et al. The continuing story of class IIa bacteriocins. Microbiol Mol Biol Rev 2006;70:564–82
   PubMed Web of Science ®Google Scholar
• Wiedemann I, Breukink E, van Kraaij C, et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J Biol Chem 2001;19:1772–9
   Google Scholar